Duke Team


Neil Johnson is an Executive Director and Duke Royalty’s Chief Executive Officer with responsibility for the overall strategic direction and performance of the company. Working closely with the other Board members and the Investment Committee, he leads all deal origination, due diligence and structuring. 

Mr. Johnson has over 20 years of experience in investment banking, merchant banking, and research analysis in both the Canadian and UK capital markets. In 2012 he co-founded and became Chief Executive Officer of Difference Capital Financial, a Canadian publicly listed merchant bank. For the previous 19 years he worked for Canaccord Genuity, first in Canada and later at Canaccord London rising to the positions of Head of Corporate Finance (Europe), Global Head of Technology, and a member of the Global Executive Committee. Mr. Johnson was instrumental in the firm becoming authorised as a nominated adviser for AIM and regulated in the UK and London Stock Exchange Main Market listings; he spearheaded the firm's diversification into the technology industry, and led Canaccord’s initiative to attract North American firms to list in London. 

During his tenure the Canaccord European operation grew revenues from less than £5 million to over £50 million, completed over 100 transactions and raised in excess of £3 billion for North American companies listed in London.  

Mr. Johnson is a graduate of the Richard Ivey School of Business at the University of Western Ontario and holds the designation of Chartered Financial Analyst Charterholder.

Image result for linkedinLinkedIn 

 

Jim Webster is Duke Royalty’s Chief Investment Officer, with responsibility to oversee the due diligence and negotiations on prospective investment opportunities for the Company; direct the execution of royalty transactions approved by the Duke Royalty board; and monitor royalty investments made by the Company.

Prior to joining the Company, between 2003 and 2009, as Managing Partner and Chair of the Investment Committee for Capital Royalty Partners LLC (now CRG L.P.), Mr. Webster was instrumental in raising $325 million for the firm’s first fund. In his capacity as Chair of its Investment Committee, he led due diligence and negotiations on royalty interests for the firm. Today, CRG L.P. has approximately $2 billion under management. 

Between 1993 and 2002, from virtually the inception of Drug Royalty Corporation Inc, Mr. Webster was a senior member of the world’s first public pharmaceutical based royalty company, listed on the Toronto Stock Exchange. Mr. Webster served in various capacities including President, Chief Executive Officer, and Chairman of its Investment Committee and oversaw the firm’s growth from its startup phase through to its eventual sale in 2012 for C$133m. At Drug Royalty Corporation Inc, he identified, assessed and negotiated investments in the pharmaceutical and biotechnology sectors. The company (now DRI Capital Inc) continues to be a leading royalty investor, with over $3 billion under management.

Mr. Webster holds a Masters of Business Administration from the Richard Ivey School of Business, and is also a CFA Charterholder and a Canadian Professional Accountant of Canada. He also completed the Columbia Executive Management Program in New York.

Justin Cochrane is responsible for helping direct Duke Royalty's business strategy and leads all business development efforts.

Prior to joining Duke Mr. Cochrane was the Executive Vice President of Corporate Development for Sandstorm Gold Ltd. At Sandstorm, Mr. Cochrane was responsible for sourcing, negotiating and executing royalty and stream financing transactions across the globe. Mr. Cochrane was a key part of Sandstorm's team as it grew into one of the largest royalty and stream financing companies in Canada. Prior to Sandstorm Mr. Cochrane was a Vice President at National Bank Financial where he spent some nine years working in the investment banking group. As Vice President, Mr. Cochrane managed primary coverage of BC based clients in the diversified, paper & forest products, power & utilities, resources, cleantech and other sectors. Mr. Cochrane specialised in providing advice to clients on merger and acquisition transactions and equity and debt financing opportunities.

Mr. Cochrane holds the designation of Chartered Financial Analyst Charterholder and received a Bachelor of Commerce degree, with honours, from the University of British Columbia, Vancouver, Canada. Mr. Cochrane is a government ambassador at the Multiple Sclerosis Society of Canada and also a director of Antipodes Gold Limited.

Mr. Cochrane is employed by Abingdon Capital Corporation which has a support services contract with Duke Royalty Limited.  

Image result for linkedinLinkedIn

Charlie Cannon-Brookes is an Executive Director of the company and works alongside the CEO on deal origination, due diligence and structuring. In addition Mr. Cannon-Brookes is Duke Royalty’s liason with UK institutions / advisors and has oversight of Duke Royalty’s corporate governance and UK plc responsibilities. 

Mr. Cannon-Brookes has over 15 years investment experience. He is the Investment Director of FCA authorised and regulated Arlington Group Asset Management Limited (AGAM) having acquired the business in October 2004. Through AGAM, Mr. Cannon-Brookes has been active in a variety of different investment management mandates and corporate finance transactions. In addition, he has successfully led a number of IPO and RTO transactions on the London markets. Prior to AGAM he worked for Arlington Group plc, an AIM quoted investment company and managed all of its public equity portfolio, as well as Jupiter Asset Management, ABN Amro and Barclays de Zoete Wedd. He has extensive fund management experience and has advised and sat on the board of a number of different funds, trusts and other operating public companies.

Mr. Cannon-Brookes holds a BA Honours degree in Economics & Politics from the University of Exeter.

Image result for linkedinLinkedIn

 

Ross Ainger is responsible for operations and investor relations activities at Duke Royalty. He began his financial career in 2002 at Reuters, subsequently worked for Deutsche Bank and then Merrill Lynch Investment Managers. Mr. Ainger joined Arlington Group Asset Management Limited in 2006, is a director of the company and has responsibility for the operations, compliance and finance functions of the business. He has been FCA approved since 2007 and currently holds the CF1, CF10, CF11 and CF30 FCA controlled functions.

Mr. Ainger has worked with other UK firms on attaining FCA authorisation and held board positions at these firms post granting of authorisation by the FCA. He has extensive public company transaction experience having worked on a number of RTOs and IPOs on the London markets. Mr. Ainger holds a BA Honours degree in Business Studies.

Mr. Ainger is employed by Arlington Group Asset Management Limited which has a support services contract with Duke Royalty Limited. 

Image result for linkedinLinkedIn

Jason Carter is responsible for helping with due diligence, deal structuring and business development activities. Prior to joining Duke in 2015, Mr. Carter was an Equity Advisory Associate with Scotia Capital's Portfolio Advisory Group where he consulted ScotiaMcLeod Advisors on investment selection and portfolio composition for high net worth private clients.

Mr. Carter received a Bachelor of Management and Organisational Studies with an Honours Specialisation in Finance from the University of Western Ontario, London, Canada. He was also educated at the University of Copenhagen in Denmark where he studied International Economics. Mr. Carter is a candidate for the Chartered Financial Analyst (CFA) designation.

Mr. Carter is employed by Abingdon Capital Corporation which has a support services contract with Duke Royalty Limited.  

Image result for linkedinLinkedIn

 

Delivered by Investis – link to website (opens in a new window)